2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

Introduction Central Artery to No Qualifier with Antiarrhythmic, Percutaneous Approach - 3E063RZ
Introduction Central Artery to No Qualifier with Destructive Agent, Percutaneous Approach - 3E063TZ
Introduction Central Artery to Insulin with Hormone, Percutaneous Approach - 3E063VG
Introduction Central Artery to Human B-type Natriuretic Peptide with Hormone, Percutaneous Approach - 3E063VH
Introduction Central Artery to Other Hormone with Hormone, Percutaneous Approach - 3E063VJ
Introduction Central Artery to Immunostimulator with Immunotherapeutic, Percutaneous Approach - 3E063WK
Introduction Central Artery to Immunosuppressive with Immunotherapeutic, Percutaneous Approach - 3E063WL
Introduction Central Artery to No Qualifier with Vasopressor, Percutaneous Approach - 3E063XZ
Introduction Coronary Artery to Recombinant Human-activated Protein C with Thrombolytic, Open Approach - 3E07016
Introduction Coronary Artery to Other Thrombolytic with Thrombolytic, Open Approach - 3E07017
Introduction Coronary Artery to Other Substance with Other Therapeutic Substance, Open Approach - 3E070GC
Introduction Coronary Artery to No Qualifier with Other Diagnostic Substance, Open Approach - 3E070KZ
Introduction Coronary Artery to No Qualifier with Platelet Inhibitor, Open Approach - 3E070PZ
Introduction Coronary Artery to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach - 3E07316
Introduction Coronary Artery to Other Thrombolytic with Thrombolytic, Percutaneous Approach - 3E07317
Introduction Coronary Artery to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E073GC
Introduction Coronary Artery to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E073KZ
Introduction Coronary Artery to No Qualifier with Platelet Inhibitor, Percutaneous Approach - 3E073PZ
Introduction Coronary Artery to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E074GC
Introduction Heart to Recombinant Human-activated Protein C with Thrombolytic, Open Approach - 3E08016
Introduction Heart to Other Thrombolytic with Thrombolytic, Open Approach - 3E08017
Introduction Heart to Other Substance with Other Therapeutic Substance, Open Approach - 3E080GC
Introduction Heart to No Qualifier with Other Diagnostic Substance, Open Approach - 3E080KZ
Introduction Heart to No Qualifier with Platelet Inhibitor, Open Approach - 3E080PZ
Introduction Heart to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach - 3E08316
Introduction Heart to Other Thrombolytic with Thrombolytic, Percutaneous Approach - 3E08317
Introduction Heart to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E083GC
Introduction Heart to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E083KZ
Introduction Heart to No Qualifier with Platelet Inhibitor, Percutaneous Approach - 3E083PZ
Introduction Heart to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E084GC
Introduction Nose to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E09305
Introduction Nose to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0930M
Introduction Nose to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E09328
Introduction Nose to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E09329
Introduction Nose to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0933Z
Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E0934Z
Introduction Nose to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E093BZ
Introduction Nose to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E093GC
Introduction Nose to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E093HZ
Introduction Nose to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E093KZ
Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E093NZ
Introduction Nose to No Qualifier with Destructive Agent, Percutaneous Approach - 3E093TZ
Introduction Nose to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E09705
Introduction Nose to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0970M
Introduction Nose to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E09728
Introduction Nose to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E09729
Introduction Nose to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0973Z
Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, Via Natural or Artificial Opening Approach - 3E0974Z
Introduction Nose to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E097BZ
Introduction Nose to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E097GC
Introduction Nose to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E097HZ
Introduction Nose to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E097KZ
Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E097NZ
Introduction Nose to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E097TZ
Introduction Nose to Other Antineoplastic with Antineoplastic, External Approach - 3E09X05
Introduction Nose to Monoclonal Antibody with Antineoplastic, External Approach - 3E09X0M
Introduction Nose to Oxazolidinones with Anti-infective, External Approach - 3E09X28
Introduction Nose to Other Anti-infective with Anti-infective, External Approach - 3E09X29
Introduction Nose to No Qualifier with Anti-inflammatory, External Approach - 3E09X3Z
Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, External Approach - 3E09X4Z
Introduction Nose to No Qualifier with Anesthetic Agent, External Approach - 3E09XBZ
Introduction Nose to Other Substance with Other Therapeutic Substance, External Approach - 3E09XGC
Introduction Nose to No Qualifier with Radioactive Substance, External Approach - 3E09XHZ
Introduction Nose to No Qualifier with Other Diagnostic Substance, External Approach - 3E09XKZ
Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, External Approach - 3E09XNZ
Introduction Nose to No Qualifier with Destructive Agent, External Approach - 3E09XTZ
Introduction Bone Marrow to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0A305
Introduction Bone Marrow to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0A30M
Introduction Bone Marrow to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0A3GC
Introduction Ear to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0B304
Introduction Ear to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0B305
Introduction Ear to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0B30M
Introduction Ear to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0B328
Introduction Ear to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0B329
Introduction Ear to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0B33Z
Introduction Ear to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0B3BZ
Introduction Ear to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0B3GC
Introduction Ear to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0B3HZ
Introduction Ear to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0B3KZ
Introduction Ear to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0B3NZ
Introduction Ear to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0B3TZ
Introduction Ear to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0B704
Introduction Ear to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0B705
Introduction Ear to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0B70M
Introduction Ear to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0B728
Introduction Ear to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0B729
Introduction Ear to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0B73Z
Introduction Ear to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0B7BZ
Introduction Ear to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0B7GC
Introduction Ear to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0B7HZ
Introduction Ear to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0B7KZ
Introduction Ear to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0B7NZ
Introduction Ear to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0B7TZ
Introduction Ear to Liquid Brachytherapy Radioisotope with Antineoplastic, External Approach - 3E0BX04
Introduction Ear to Other Antineoplastic with Antineoplastic, External Approach - 3E0BX05
Introduction Ear to Monoclonal Antibody with Antineoplastic, External Approach - 3E0BX0M
Introduction Ear to Oxazolidinones with Anti-infective, External Approach - 3E0BX28
Introduction Ear to Other Anti-infective with Anti-infective, External Approach - 3E0BX29
Introduction Ear to No Qualifier with Anti-inflammatory, External Approach - 3E0BX3Z
Introduction Ear to No Qualifier with Anesthetic Agent, External Approach - 3E0BXBZ

« Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next »